drugset / Trial / NCT04118010

Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis

NCT04118010

Phase 4 Completed 40 enrolled Emory University
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will assess if administration of high-dose vitamin D and a commonly used prebiotic (inulin) is effective to reduce gastrointestinal dysbiosis and to improve critical intestinal functions in Cystic Fibrosis with the additive or synergistic effects of the combination of vitamin D + inulin.

Timeline

Start
2020-03-13
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu
Comparator Inulin Other / unclassified 12 g

Indications